Inovio’s (INO) INO-4800 can be a Valuable Vaccine Arsenal Upon FDA Approval

Wasatch Advisors, an employee-owned investment manager, published its ‘Wasatch Micro Cap Value Fund’ third-quarter 2020 Investor Letter – a copy of which can be downloaded here. A return of 11.62% was recorded by the fund for the Q3 of 2020, above its Russel Microcap benchmark that returned 3.69%. You can view the fund’s top 10 holdings to have a peek at their top bets for 2021.

Wasatch Advisors, in their Q3 2020 Investor Letter said that they still believe in the capabilities of...